West Family Investments Inc. Makes New $828,000 Investment in Boston Scientific Corporation $BSX

West Family Investments Inc. acquired a new stake in Boston Scientific Corporation (NYSE:BSX – Free Report) in the 3rd quarter, HoldingsChannel.com reports. The fund acquired 18,958 shares of the medical equipment provider’s stock, valued at approximately $828,000.

Several other large investors have also bought and sold shares of the company. Vectors Research Management LLC lifted its holdings in Boston Scientific by 4.4% in the 3rd quarter. Vectors Research Management LLC now owns 13,674 shares of the medical equipment provider’s stock valued at $597,000 after acquiring an additional 571 shares during the last quarter. Optas LLC acquired a new position in shares of Boston Scientific in the 3rd quarter worth approximately $254,000. Drive Wealth Management LLC acquired a new position in shares of Boston Scientific in the 3rd quarter worth approximately $554,000. Mawer Investment Management Ltd. raised its holdings in shares of Boston Scientific by 70.5% in the 3rd quarter. Mawer Investment Management Ltd. now owns 904,543 shares of the medical equipment provider’s stock worth $39,483,000 after purchasing an additional 374,010 shares in the last quarter. Finally, Diversified Trust Co raised its holdings in shares of Boston Scientific by 204.8% in the 3rd quarter. Diversified Trust Co now owns 33,326 shares of the medical equipment provider’s stock worth $1,455,000 after purchasing an additional 22,391 shares in the last quarter. Institutional investors own 89.07% of the company’s stock.

Boston Scientific Trading Down 0.0%

Shares of BSX opened at $44.33 on Monday. The business’s 50-day moving average price is $44.00 and its 200 day moving average price is $54.50. The company has a current ratio of 1.36, a quick ratio of 0.81 and a debt-to-equity ratio of 0.42. The stock has a market capitalization of $64.25 billion, a P/E ratio of 18.78, a P/E/G ratio of 1.31 and a beta of 0.60. Boston Scientific Corporation has a 1-year low of $39.57 and a 1-year high of $104.61.

Boston Scientific (NYSE:BSX – Get Free Report) last posted its quarterly earnings data on Wednesday, October 28th. The medical equipment provider reported $0.73 EPS for the quarter, meeting analysts’ consensus estimates of $0.73. Boston Scientific had a net margin of 16.62% and a return on equity of 18.61%. The company had revenue of $5.14 billion during the quarter, compared to analyst estimates of $5.09 billion. During the same period in the prior year, the firm earned $0.75 earnings per share. The business’s quarterly revenue was up 1.4% on a year-over-year basis. Analysts expect that Boston Scientific Corporation will post 3.17 earnings per share for the current year.

Analysts Set New Price Targets

Several research firms recently commented on BSX. Wall Street Zen lowered shares of Boston Scientific from a “buy” rating to a “hold” rating in a research note on Sunday, August 2nd. Needham & Company LLC decreased their price target on shares of Boston Scientific from $57.00 to $48.00 and set a “buy” rating on the stock in a research report on Wednesday, October 28th. Mizuho set a $50.00 price target on shares of Boston Scientific in a research report on Thursday, October 29th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Boston Scientific in a report on Friday, October 2nd. Finally, Leerink Partners cut their price objective on Boston Scientific from $55.00 to $50.00 and set an “outperform” rating for the company in a research report on Thursday, October 29th. One analyst has rated the stock with a Strong Buy rating, twenty have assigned a Buy rating, eight have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $61.43.

Check Out Our Latest Stock Report on Boston Scientific

Boston Scientific Company Profile

(Free Report)

Boston Scientific is a medical technology company that develops, manufactures and markets devices used in minimally invasive procedures across a range of medical specialties. Founded in 1979, the company is headquartered in Marlborough, Massachusetts. Its products support areas including cardiovascular care, endoscopy, urology and neuromodulation. They include catheter-based devices and therapies for conditions affecting the heart and blood vessels, as well as devices used in diagnostic and therapeutic procedures involving the digestive and urinary systems.

Recommended Stories

Want to see what other hedge funds are holding BSX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Boston Scientific Corporation (NYSE:BSX – Free Report).

Institutional Ownership by Quarter for Boston Scientific (NYSE:BSX)

Receive News & Ratings for Boston Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Boston Scientific and related companies with MarketBeat.com's FREE daily email newsletter.